IRIS
BALAGURA, GANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.313
AS - Asia 28
NA - Nord America 2
SA - Sud America 1
Totale 2.344
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.312
CN - Cina 26
US - Stati Uniti d'America 2
BR - Brasile 1
FI - Finlandia 1
ID - Indonesia 1
VN - Vietnam 1
Totale 2.344
Salva come PNG Salva come JPEG
Città #
Genoa 1.208
Genova 492
Vado Ligure 304
Rapallo 302
Beijing 12
Bordighera 5
Ashburn 2
Hanoi 1
Lappeenranta 1
Milan 1
São Paulo 1
Totale 2.329
Salva come PNG Salva come JPEG
Nome #
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders 189
No evidence for a BRD2 promoter hypermethylation in blood leukocytes of Europeans with juvenile myoclonic epilepsy 136
The bedside and the bench of STXBP1-DEE in the wake of precision medicine 132
Clinical spectrum and genotype-phenotype correlations in PRRT2 Italian patients 126
Emerging treatments for progressive myoclonus epilepsies 107
Genotype-phenotype correlations in patients with de novo KCNQ2 pathogenic variants 101
Loss of Wwox Perturbs Neuronal Migration and Impairs Early Cortical Development 100
GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture 95
A Phenotypic-Driven Approach for the Diagnosis of WOREE Syndrome 92
Epilepsy Course and Developmental Trajectories in STXBP1-DEE 85
Adjunctive rufinamide in children with lennox-gastaut syndrome: A literature review 84
Pharmacokinetics and drug interaction of antiepileptic drugs in children and adolescents 84
Fenfluramine for the Treatment of Dravet Syndrome and Lennox–Gastaut Syndrome 83
Genotype-phenotype correlations and disease mechanisms in PEX13-related Zellweger spectrum disorders 82
Targeted re-sequencing in malformations of cortical development: genotype-phenotype correlations 82
Emerging drugs for the treatment of Dravet syndrome 68
Diagnostic Approach to Macrocephaly in Children 68
De novo truncating NOVA2 variants affect alternative splicing and lead to heterogeneous neurodevelopmental phenotypes 64
Allelic heterogeneity and abnormal vesicle recycling in PLAA-related neurodevelopmental disorders 62
New Trends and Most Promising Therapeutic Strategies for Epilepsy Treatment 60
Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood 58
Vesicular glutamate release from feeder-free hiPSC-derived neurons 58
Moving beyond sodium valproate: choosing the right anti-epileptic drug in children 56
Assessing the landscape of STXBP1-related disorders in 534 individuals 56
Current and promising therapeutic options for Dravet syndrome 53
An Open Retrospective Study of a Standardized Cannabidiol Based-Oil in Treatment-Resistant Epilepsy 52
null 41
STXBP1 Syndrome Is Characterized by Inhibition-Dominated Dynamics of Resting-State EEG 40
Identification of Central Nervous System Oncologic Disease Biomarkers in EVs from Cerebrospinal Fluid (CSF) of Pediatric Patients: A Pilot Neuro-Proteomic Study 32
Intramuscular Midazolam for treatment of Status Epilepticus 30
Temporal-parietal-occipital epilepsy in GEFS+ associated with SCN1A mutation 21
Totale 2.397
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.033
article - articoli 10.681
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.714
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021219 0 0 0 71 7 4 4 28 10 33 40 22
2021/2022192 8 4 5 8 10 15 11 35 11 44 5 36
2022/2023358 24 40 11 48 44 47 2 26 54 5 38 19
2023/2024266 11 28 8 28 28 54 11 18 10 9 30 31
2024/2025881 37 47 30 50 102 79 106 161 55 48 97 69
2025/2026368 148 32 107 81 0 0 0 0 0 0 0 0
Totale 2.397